Myfortic news from FierceHealthcare
NewsALSO NOTED: Wireless "white spaces" could disrupt care; MA hopes "medical homes" catch on; and much more...
> With telecommunications industry pressure mounting to put them to use, technology vendors and engineering groups are fighting what they say is a critical battle to protect so-called "white Read more...
ALSO NOTED: FDA investigates Roche, Novartis transplant drugs; Maryland hospital fined for radiation errors; and much more...
> The FDA has started to investigate whether Roche's CellCept and Novartis' Myfortic, similar drugs used in transplants to prevent organ rejection, cause an often-fatal neurological disease. Read more...
|
